|
168
|
611
|
9z9eA |
Structure of fabs1ce2_er-3c in complex with the extracellular region of egfr |
|
44
|
226
|
9z9eD |
Structure of fabs1ce2_er-3c in complex with the extracellular region of egfr |
|
50
|
212
|
9z9eE |
Structure of fabs1ce2_er-3c in complex with the extracellular region of egfr |
|
84
|
321
|
9os6A |
Canertinib (ci-1033) in complex with wild-type egfr |
|
84
|
320
|
9njnA |
Yk-029a in complex with wt egfr |
|
92
|
321
|
9msrA |
Bdtx-1535 in complex with wt egfr |
|
86
|
321
|
9nisA |
Alflutinib in complex with wt egfr |
|
84
|
322
|
9nm0A |
Az5104 (metabolite of azd9291) in complex with wt egfr |
|
81
|
320
|
9nj7A |
Almonertinib in complex with wt egfr |
|
87
|
320
|
9nhwA |
Oritinib in complex with wt egfr |
|
87
|
321
|
9mssA |
Limertinib in complex with wt egfr |
|
87
|
322
|
9mstA |
Befotertinib in complex with wt egfr |
|
69
|
297
|
9u8cA |
Crystal structure of egfr exon20 insertion mutant in complex with enozertinib (oric-114) |
|
88
|
322
|
9pmzA |
Icotinib in complex with wild-type egfr |
|
134
|
631
|
9p9uA |
Egfr-kdd with compound2 |
|
89
|
321
|
9ngpA |
Egfr wildtype in complex with bi-4732 |
|
95
|
322
|
9dm8A |
Egfr wildtype in complex with bi-8128 |
|
44
|
213
|
9z2hL |
Crystal structure of a10 fab in complex with the egfr peptide |
|
36
|
219
|
9z2hH |
Crystal structure of a10 fab in complex with the egfr peptide |
|
2
|
18
|
9z2hA |
Crystal structure of a10 fab in complex with the egfr peptide |
|
74
|
276
|
9u91A |
Complex of compound 31r and egfr del19/t790m/c797s/v948r |
|
88
|
322
|
9ghvA |
Crystal structure of egfr-wt in complex with covalent compound 13 |
|
90
|
324
|
9ghrA |
Crystal structure of egfr-wt in complex with covalent compound 10n |
|
88
|
323
|
9ghtA |
Crystal structure of egfr-wt in complex with bi-4020 |
|
88
|
324
|
9ghuA |
Crystal structure of egfr-wt in complex with covalent compound 10f |
|
87
|
324
|
9ghsA |
Crystal structure of egfr-wt in complex with covalent compound 10a |
|
96
|
324
|
9s3xA |
Egfr (t790m,l858r) in complex with ncl-26007 |
|
89
|
325
|
9h42A |
Egfr wild type incomplex with 26007 |
|
90
|
325
|
9h47A |
Egfr wild type in complex with 26313 |
|
86
|
325
|
9xu9A |
Crystal structure of egfr t790m/c797s/l858r mutant in complex with (2-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)-5-nitrophenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide |
|
91
|
322
|
9q0sA |
Jcn037 in complex with wild-type egfr |
|
89
|
321
|
9ou9A |
Azd3759 in complex with wild-type egfr |
|
101
|
326
|
9qxnAAA |
Crystal structure of wild-type egfr in complex with the reversible inhibitor sevabertinib (bay 2927088) |
|
53
|
485
|
9ipdB |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (middle conformation) |
|
22
|
204
|
9ipdC |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (middle conformation) |
|
22
|
204
|
9ipcC |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (closed conformation) |
|
87
|
584
|
9ip7A |
Local refinement structure of segfr and 528 fv (from hl-type bispecific diabody ex3) complex |
|
45
|
492
|
9ip9B |
Poly-alanine model for hl-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (middle conformation) |
|
44
|
255
|
9ip7D |
Local refinement structure of segfr and 528 fv (from hl-type bispecific diabody ex3) complex |
|
41
|
584
|
9ip8A |
Poly-alanine model for hl-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (closed conformation) |
|
55
|
593
|
9ipeA |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (open conformation) |
|
48
|
485
|
9ipeB |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (open conformation) |
|
58
|
593
|
9ipcA |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (closed conformation) |
|
114
|
593
|
9ipbA |
Local refinement structure of segfr and 528 fv (from lh-type bispecific diabody ex3) complex |
|
56
|
485
|
9ipcB |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (closed conformation) |
|
21
|
204
|
9ipaC |
Poly-alanine model for hl-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (open conformation) |
|
50
|
492
|
9ip8B |
Poly-alanine model for hl-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (closed conformation) |
|
46
|
250
|
9ipbD |
Local refinement structure of segfr and 528 fv (from lh-type bispecific diabody ex3) complex |
|
50
|
492
|
9ipaB |
Poly-alanine model for hl-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (open conformation) |
|
22
|
204
|
9ipeC |
Poly-alanine model for lh-type bispecific diabody ex3 composed of 528 and okt3 fvs in ternary complex with segfr and cd3gamma-epsilon (open conformation) |
